Alambic Investment Management’s St Jude Medical STJ Stock Holding History

Alambic Investment Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,400	Closed	-$273K	–	722
2016 Q4	$273K	Hold	3,400	–	–	0.05%	444
2016 Q3	$271K	Sell	3,400 -900	-21%	-$72.7K	0.06%	386
2016 Q2	$335K	Buy	+4,300	New	+$307K	0.08%	361
2016 Q1	–	Sell	-4,010	Closed	-$248K	–	565
2015 Q4	$248K	Buy	+4,010	New	+$253K	0.15%	252

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alambic Investment Management's STJ Position: Q1 2017 in Review

Alambic Investment Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,400 shares — an estimated $273K sold.

Alambic Investment Management first reported a position in STJ in Q4 2015 and held it in 4 quarters. The position peaked at $335K in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Alambic Investment Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Alambic Investment Management sold 3,400 St Jude Medical shares in Q1 2017, an estimated $273K.
Alambic Investment Management first reported a position in St Jude Medical in Q4 2015 and held it in 4 quarters.
Alambic Investment Management's St Jude Medical position peaked at $335K in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Alambic Investment Management's 13F filing for Q1 2017, filed 9 May 2017.